OSG Q2 Earnings Call Focuses on MGA Growth and Mixed Guidance

Octave Specialty Group raises 2026 Distribution growth and EBITDA guidance as MGA momentum accelerates, while cutting EPS and Everspan outlooks.

Zacks Investment Research • Aug 10, 2026

OSG Q2 Earnings Miss Estimates, Revenues Beat on Distribution Growth

OSG's Q2 revenues jumped 51% on strong Insurance Distribution growth and improving Everspan results, prompting a higher 2026 distribution outlook.

Zacks Investment Research • Aug 10, 2026

Octave Specialty Group Q2 Earnings Call Highlights

Octave Specialty Group NYSE: OSG reported improved second-quarter results as growth in its Insurance Distribution segment and progress at its Everspan specialty insurance platform narrowed its net loss and lifted adjusted EBITDA.

MarketBeat • Aug 9, 2026

Octave Specialty Group, Inc. (OSG) Q2 2026 Earnings Call Transcript

Octave Specialty Group, Inc. (OSG) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 7, 2026

Octave Specialty Group Reports Second Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--Octave Specialty Group Reports Second Quarter 2026 Results.

Business Wire • Aug 6, 2026

Octave Specialty Group (OSG) Reports Q2 Loss, Beats Revenue Estimates

Octave Specialty Group (OSG) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.22 per share a year ago.

Zacks Investment Research • Aug 6, 2026

Octave Specialty Group to Report Q2 Earnings: What to Expect

Octave Specialty heads into Q2 results with revenues projected to jump 47.4%. The bottom line is likely to improve y/y, though the model does not signal a beat.

Zacks Investment Research • Aug 3, 2026

Octave Specialty Group to Release Second Quarter 2026 Results on August 6, 2026

NEW YORK--(BUSINESS WIRE)--Octave Specialty Group to Release Second Quarter 2026 Results on August 6, 2026.

Business Wire • Jul 17, 2026

Octave Specialty (OSG) Soars 8.5%: Is Further Upside Left in the Stock?

Octave Specialty (OSG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research • Jun 29, 2026

Octave Specialty (OSG) Upgraded to Strong Buy: Here's Why

Octave Specialty (OSG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research • Jun 16, 2026